newsfilter
← Latest News
PR Newswire·

/C O R R E C T I O N -- NeuroSense/

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...